Clamping Cords Too Soon?

A review study indicates that clamping umbilical cords immediately after birth, rather than waiting a few minutes, may increase the risk of iron and hemoglobin deficiency in infants.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, DAVE HERHOLZWhen a baby comes out of its mother, it is still attached to her via the umbilical cord and still hooked into her blood supply. Ordinarily, the umbilical cord is clamped and then cut within the first minute after birth. But a new paper published in The Cochrane Database of Systematic Reviews last week (July 11) indicates that babies may fare better if the cord is cut a few minutes later, allowing more blood to flow from mother to child.

“A more liberal approach to delaying clamping of the umbilical cord in healthy term infants appears to be warranted, particularly in light of growing evidence that delayed cord clamping increases early hemoglobin concentrations and iron stores in infants,” the authors wrote in their review.

The researchers looked at data from 15 trials that analyzed how 3,911 mother-infant pairs fared after delivery. The babies’ cords were generally clamped between 1 and 3 minutes after birth. The researchers found that regardless of when clamping occurred, the mothers had around the same risk of dangerous postpartum hemorrhage.

Meanwhile, babies whose cords were cut slightly later tended to have higher birth weights and higher hemoglobin concentrations directly after birth, and improved iron levels for up to half a year ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies